E Renaud

2PUBLICATIONS

3CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Mar 16, 2023

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

D Bello Roufai, A Gonçalves, T De La Motte Rouge

|Jan 07, 2023

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

D Bello Roufai, A Gonçalves, T De La Motte Rouge

Pageof 1

Frequent Collaborators

2 joint publications

D Bello Roufai

2 joint publications

S Delaloge

2 joint publications

F C Bidard

Frequent Collaborators

2 joint publications

D Bello Roufai

2 joint publications

S Delaloge

2 joint publications

F C Bidard